271 related articles for article (PubMed ID: 24509604)
1. Distinctive cytokine, chemokine, and antibody responses in Echinococcus multilocularis-infected patients with cured, stable, or progressive disease.
Huang X; Grüner B; Lechner CJ; Kern P; Soboslay PT
Med Microbiol Immunol; 2014 Jun; 203(3):185-93. PubMed ID: 24509604
[TBL] [Abstract][Full Text] [Related]
2. Echinococcus multilocularis: inflammatory and regulatory chemokine responses in patients with progressive, stable and cured alveolar echinococcosis.
Kocherscheidt L; Flakowski AK; Grüner B; Hamm DM; Dietz K; Kern P; Soboslay PT
Exp Parasitol; 2008 Aug; 119(4):467-474. PubMed ID: 18490012
[TBL] [Abstract][Full Text] [Related]
3. Echinococcus multilocularis specific antibody, systemic cytokine, and chemokine levels, as well as antigen-specific cellular responses in patients with progressive, stable, and cured alveolar echinococcosis: A 10-year follow-up.
Grüner B; Peters L; Hillenbrand A; Voßberg P; Schweiker J; Rollmann EG; Rodriguez LH; Blumhardt J; Burkert S; Kern P; Köhler C; Soboslay PT
PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010099. PubMed ID: 35108275
[TBL] [Abstract][Full Text] [Related]
4. Echinococcus multilocularis metacestodes modulate cellular cytokine and chemokine release by peripheral blood mononuclear cells in alveolar echinococcosis patients.
Hübner MP; Manfras BJ; Margos MC; Eiffler D; Hoffmann WH; Schulz-Key H; Kern P; Soboslay PT
Clin Exp Immunol; 2006 Aug; 145(2):243-51. PubMed ID: 16879243
[TBL] [Abstract][Full Text] [Related]
5. An Echinococcus multilocularis Antigen B3 Proteoform That Shows Specific Antibody Responses to Active-Stage Alveolar Echinococcosis.
Ahn CS; Cai H; Kim JG; Han X; Ma X; Bae YA; Yang HJ; Kang I; Wang H; Kong Y
J Clin Microbiol; 2015 Oct; 53(10):3310-7. PubMed ID: 26269620
[TBL] [Abstract][Full Text] [Related]
6. Subclass-specific serological reactivity and IgG4-specific antigen recognition in human echinococcosis.
Dreweck CM; Lüder CG; Soboslay PT; Kern P
Trop Med Int Health; 1997 Aug; 2(8):779-87. PubMed ID: 9294548
[TBL] [Abstract][Full Text] [Related]
7. Parasite-specific IL-17-type cytokine responses and soluble IL-17 receptor levels in Alveolar Echinococcosis patients.
Lechner CJ; Grüner B; Huang X; Hoffmann WH; Kern P; Soboslay PT
Clin Dev Immunol; 2012; 2012():735342. PubMed ID: 22969818
[TBL] [Abstract][Full Text] [Related]
8. Impact of Albendazole on Cytokine and Chemokine Response Profiles in
Wu J; Ma HZ; Apaer S; Anweier N; Zeng Q; Fulati X; Li T; Zhao JM; Wen H; Tuxun T
Biomed Res Int; 2021; 2021():6628814. PubMed ID: 34041299
[TBL] [Abstract][Full Text] [Related]
9. Cellular immune response in Echinococcus multilocularis infection in humans. I. Lymphocyte reactivity to Echinococcus antigens in patients with alveolar echinococcosis.
Bresson-Hadni S; Vuitton DA; Lenys D; Liance M; Racadot E; Miguet JP
Clin Exp Immunol; 1989 Oct; 78(1):61-6. PubMed ID: 2805424
[TBL] [Abstract][Full Text] [Related]
10. Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice.
Wang J; Vuitton DA; Müller N; Hemphill A; Spiliotis M; Blagosklonov O; Grandgirard D; Leib SL; Shalev I; Levy G; Lu X; Lin R; Wen H; Gottstein B
PLoS Negl Trop Dis; 2015 May; 9(5):e0003755. PubMed ID: 25955764
[TBL] [Abstract][Full Text] [Related]
11. Serological diagnosis of echinococcosis: the diagnostic potential of native antigens.
Schweiger A; Grimm F; Tanner I; Müllhaupt B; Bertogg K; Müller N; Deplazes P
Infection; 2012 Apr; 40(2):139-52. PubMed ID: 22076692
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional profiles of cytokine/chemokine factors of immune cell-homing to the parasitic lesions: a comprehensive one-year course study in the liver of E. multilocularis-infected mice.
Wang J; Lin R; Zhang W; Li L; Gottstein B; Blagosklonov O; Lü G; Zhang C; Lu X; Vuitton DA; Wen H
PLoS One; 2014; 9(3):e91638. PubMed ID: 24637903
[TBL] [Abstract][Full Text] [Related]
13. Specific cellular and humoral immune responses induced by different antigen preparations of Echinococcus multilocularis metacestodes in patients with alveolar echinococcosis.
Nicod L; Bresson-Hadni S; Vuitton DA; Emery I; Gottstein B; Auer H; Lenys D
Parasite; 1994 Sep; 1(3):261-70. PubMed ID: 9140493
[TBL] [Abstract][Full Text] [Related]
14. Impeded Th1 CD4 memory T cell generation in chronic-persisting liver infection with Echinococcus multilocularis.
Manfras BJ; Reuter S; Wendland T; Boehm BO; Kern P
Int Immunol; 2004 Jan; 16(1):43-50. PubMed ID: 14688059
[TBL] [Abstract][Full Text] [Related]
15. Improved serodiagnosis of alveolar echinococcosis of humans using an in vitro-produced Echinococcus multilocularis antigen.
Müller N; Frei E; Nuñez S; Gottstein B
Parasitology; 2007 Jun; 134(Pt 6):879-88. PubMed ID: 17306060
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the diagnostic value of the ELISA tests developed by using EgHF, Em2 and EmII/3-10 antigens in the serological diagnosis of alveolar echinococcosis].
Pektaş B; Altintaş N; Akpolat N; Gottstein B
Mikrobiyol Bul; 2014 Jul; 48(3):461-8. PubMed ID: 25052112
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis.
Sturm D; Menzel J; Gottstein B; Kern P
Infect Immun; 1995 May; 63(5):1688-97. PubMed ID: 7729873
[TBL] [Abstract][Full Text] [Related]
18. EmTIP, a T-Cell immunomodulatory protein secreted by the tapeworm Echinococcus multilocularis is important for early metacestode development.
Nono JK; Lutz MB; Brehm K
PLoS Negl Trop Dis; 2014; 8(1):e2632. PubMed ID: 24392176
[TBL] [Abstract][Full Text] [Related]
19. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. I. Comparison of patients with progressive and abortive lesions.
Godot V; Harraga S; Beurton I; Deschaseaux M; Sarciron E; Gottstein B; Vuitton DA
Clin Exp Immunol; 2000 Sep; 121(3):484-90. PubMed ID: 10971515
[TBL] [Abstract][Full Text] [Related]
20. The Echinococcus multilocularis 14-3-3 protein protects mice against primary but not secondary alveolar echinococcosis.
Siles-Lucas M; Merli M; Mackenstedt U; Gottstein B
Vaccine; 2003 Jan; 21(5-6):431-9. PubMed ID: 12531641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
